pharmaceuticals

Themis Medicare Ltd (THEMISMED) Q4 FY23 Earnings Concall Transcript

● May 15, 2023

Themis Medicare Ltd (NSE: THEMISMED) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Sachin Patel — Managing Director and Chief...

Gujarat Themis Biosyn Limited (506879) Q4 FY23 Earnings Concall Transcript

● May 15, 2023

Gujarat Themis Biosyn Limited (NSE: 506879) Q4 FY23 earnings concall dated May. 15, 2023 Corporate Participants: Sachin Dinesh Patel — Director Rajneesh...

Cipla Limited Q4 FY23 Earnings Conference Call Insights

● May 15, 2023

Key highlights from Cipla Limited (CIPLA) Q4 FY23 Earnings Concall Management Update: [00:05:08] CIPLA said its U.S. business crossed $200...

Solara Active Pharma Sciences Limited (SOLARA) Q4 FY23 Earnings Concall Transcript

● May 15, 2023

Solara Active Pharma Sciences Limited (NSE:SOLARA) Q4 FY23 Earnings Concall dated May. 12, 2023. Corporate Participants: Abhishek Singhal — Investor Relations Jitesh...

Solara Active Pharma Q4FY23 results out, revenue grows by 6%

● May 12, 2023

Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading...

Cipla Limited Q4 FY23; Consolidated Net Profit Jumped By 41%

● May 12, 2023

Cipla Limited reported Total Income for Q4 FY23 of ₹5,873.93 Crore up from ₹5,324.35 Crore year on year, a growth...

Dr. Reddy’s Laboratories Q4 FY23 Earnings Conference Call Insights

● May 11, 2023

Key highlights from Dr. Reddy’s Laboratories (DRREDDY) Q4 FY23 Earnings Concall Q&A Highlights: [00:21:55] Mikhaila at Barclays asked more details...

Aarti Industries Ltd Q4 FY23 Earnings Conference Call Insights

● May 10, 2023

Key highlights from Aarti Industries Ltd (AARTIIND) Q4 FY23 Earnings Concall Management Update: [00:08:20] AARTIIND said its EBITDA growth guidance...

Dr Reddy’s Laboratories Q4 FY23; Net Profit Surged Up To ₹960 Crore

● May 10, 2023

Dr. Reddy’s Laboratories Limited reported Total Income for Q4 FY23 of ₹6,453.7 Crore up from ₹5,596.8 Crore year on year,...

Sanofi Ltd Q4FY23 results out, revenue soars by 4%

● May 10, 2023

Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Company has three brands (Lantus, Allegra, Combiflam)...